Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Solid, Malignant Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00747734
What this trial is testing

MNRP1685A in Patients With Locally Advanced or Metastatic Solid Tumors

Who this might be right for
Solid Cancers
Genentech, Inc. 35
Testing effectiveness (Phase 2)Study completedNCT04570839
What this trial is testing

COM701 in Combination With BMS-986207 and Nivolumab in Subjects With Advanced Solid Tumors.

Who this might be right for
Endometrial NeoplasmsOvarian CancerSolid Tumor+1 more
Compugen Ltd 48
Early research (Phase 1)Looking for participantsNCT04842812
What this trial is testing

Engineered TILs/CAR-TILs to Treat Advanced Solid Tumors

Who this might be right for
Liver CancerLung CancerBreast Cancer+5 more
Second Affiliated Hospital of Guangzhou Medical University 40
Early research (Phase 1)Not Yet RecruitingNCT07650357
What this trial is testing

CLSP 5282 in HLA-A*03:01 Positive Adult Patients With Solid Tumors (SENTINEL-101)

Who this might be right for
Advanced Solid TumorNon Small Cell Lung CancerPancreatic Carcinoma+1 more
Clasp Therapeutics, Inc. 140
Early research (Phase 1)Study completedNCT00201812
What this trial is testing

Phase I & Biological Study of Etanercept & Weekly Docetaxel in Patients With Advanced Solid Tumors

Who this might be right for
Tumors
Ohio State University Comprehensive Cancer Center 27
Early research (Phase 1)WithdrawnNCT00997360
What this trial is testing

Study of PKI-179 Administered Orally to Subjects With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Wyeth is now a wholly owned subsidiary of Pfizer
Testing effectiveness (Phase 2)Active Not RecruitingNCT03839342
What this trial is testing

Binimetinib and Encorafenib for the Treatment of Advanced Solid Tumors With Non-V600E BRAF Mutations

Who this might be right for
Solid Tumor
University Health Network, Toronto 26
Testing effectiveness (Phase 2)Looking for participantsNCT07639450
What this trial is testing

N-3C01 Monotherapy and Combination With PD-(L)1 Inhibitors in Advanced Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Hefei Xinzhu Biological Technology Co., Ltd. 114
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06304818
What this trial is testing

Aims to Explore the Safety, Tolerability, and Preliminary Efficacy of SCTB14 in Adult Patients With Advanced Malignant Solid Tumours.

Who this might be right for
Advanced Malignant Solid Tumours
Sinocelltech Ltd. 515
Early research (Phase 1)Looking for participantsNCT06873659
What this trial is testing

SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors

Who this might be right for
Solid TumorGastric CancerLiver Cancer
Qurgen Inc. 96
Testing effectiveness (Phase 2)Study completedNCT00309179
What this trial is testing

A Phase II Study of the Safety and Efficacy of E7820 Plus Cetuximab in Colorectal Cancer, Preceded by a Run-in Study in Advanced Solid Tumors

Who this might be right for
Advanced Colorectal Cancer
Eisai Inc. 41
Early research (Phase 1)Looking for participantsNCT06958679
What this trial is testing

Evaluation of SYS6005 in Patients With Advanced Malignant Tumor

Who this might be right for
B-cell MalignanciesSolid Tumors
CSPC Megalith Biopharmaceutical Co.,Ltd. 132
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07767474
What this trial is testing

Evaluate ATX-898 in Participants With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
Antares Therapeutics, Inc 343
Early research (Phase 1)Study completedNCT00003713
What this trial is testing

Chemotherapy in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Unspecified Adult Solid Tumor, Protocol Specific
Genzyme, a Sanofi Company 35
Testing effectiveness (Phase 2)Looking for participantsNCT05204862
What this trial is testing

Phase 1/2 Study of TU2218 Alone and in Combination With Checkpoint Inhibitors in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumor
TiumBio Co., Ltd. 240
Early research (Phase 1)Study completedNCT00207103
What this trial is testing

MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
TumorsNeoplasm Metastasis
Bristol-Myers Squibb 68
Early research (Phase 1)Study completedNCT02881190
What this trial is testing

Study of RC48-ADC Administered Intravenously to Subjects With HER2-Positive in Advanced Malignant Solid Tumors

Who this might be right for
Solid Tumors
RemeGen Co., Ltd. 57
Early research (Phase 1)Looking for participantsNCT06640413
What this trial is testing

Evaluate the Safety and Preliminary Signs of Efficacy of [177Lu]Lu-OncoFAP-23 Alone or in Combination With L19-IL2 as a Treatment of Metastatic FAP-positive Solid Tumors

Who this might be right for
FAP
Philogen S.p.A. 56
Early research (Phase 1)Study completedNCT03781362
What this trial is testing

Study of CPI-100 in Patients With Advanced Tumors

Who this might be right for
Advanced Tumors
Coordination Pharmaceuticals, Inc. 36
Early research (Phase 1)Ended earlyNCT06334783
What this trial is testing

TIL for Patients With Advanced Solid Tumor

Who this might be right for
Advanced Solid Tumor
Hervor Therapeutics 5
Next Page